GSK PLC |
Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 1.787 GBX | +0,49% |
|
+0,54% | +23,05% |
| 09:56 | FTSE 100 in calo; le vendite al dettaglio crollano ad aprile | AN |
| 09:39 | GSK celebra il verdetto della giuria dell'Illinois nel caso Valadez | AN |
Attività
Numero di dipendenti: 70 212
Vendite per attività
| GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Commercial Operations
100,0
%
| 29 324 | 100,0 % | 30 328 | 100,0 % | +3,42% |
Vendite per regione
| GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
52,2
%
| 14 542 | 49,6 % | 15 820 | 52,2 % | +8,79% |
Rest of World
45,6
%
| 14 087 | 48,0 % | 13 815 | 45,6 % | -1,93% |
United Kingdom
2,3
%
| 695 | 2,4 % | 693 | 2,3 % | -0,29% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/05/10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/05/23 |
James Ford
CMP | Compliance Officer | - | 01/08/95 |
Amy Altshul
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/18 | |
Tony Wood
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/17 |
Hal Barron
BRD | Director/Board Member | 62 | 01/01/18 |
David Redfern
PRN | Corporate Officer/Principal | 57 | 01/01/94 |
Frannie DeFranco
PRN | Corporate Officer/Principal | - | 01/09/10 |
Claire Lund
PRN | Corporate Officer/Principal | - | - |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/05/23 |
Jonathan Symonds
CHM | Chairman | 66 | 01/09/19 |
Hal Barron
BRD | Director/Board Member | 62 | 01/01/18 |
Vishal Sikka
BRD | Director/Board Member | 57 | 18/07/22 |
Wendy Becker
BRD | Director/Board Member | 58 | 01/10/23 |
Charles Bancroft
BRD | Director/Board Member | 65 | 01/05/20 |
Anne Beal
BRD | Director/Board Member | 62 | 06/05/21 |
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/05/10 |
| Director/Board Member | 66 | 01/09/22 | |
Jesse Goodman
BRD | Director/Board Member | 72 | 01/01/16 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 4 314 108 510 | 4 078 458 763 ( 94,54 %) | 169 171 155 ( 3,921 %) | 94,54 % |
Partecipazioni
| Nome | Azioni | % | Valorizzazione |
|---|---|---|---|
| 127 054 524 | 75.00% | 3 178 181 250 $ | |
HALEON PLC 4.22% | 385 320 110 | 4.22% | 1 638 015 054 $ |
| 263 029 794 | 82.59% | 94 201 490 $ | |
HALEON PAKISTAN LIMITED 85.79% | 100 423 259 | 85.79% | 87 258 774 $ |
LYELL IMMUNOPHARMA, INC. 11.87% | 30 253 189 | 11.87% | 66 557 016 $ |
WAVE LIFE SCIENCES LTD. 11.44% | 13 983 761 | 11.44% | 66 283 027 $ |
VIR BIOTECHNOLOGY, INC. 6.29% | 8 550 954 | 6.29% | 65 243 779 $ |
GLAXOSMITHKLINE S.A.E 91.20% | 76 161 378 | 91.20% | 47 877 327 $ |
CUREVAC N.V. 7.41% | 16 591 937 | 7.41% | 38 327 374 $ |
DONG-A ST CO., LTD. 8.17% | 722 016 | 8.17% | 35 314 582 $ |
Coordinate società
Società del gruppo
| Nome | Categoria e settore |
|---|---|
GlaxoSmithKline Asia Pvt Ltd.
 GlaxoSmithKline Asia Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Asia Pvt Ltd. is an Indian company that produces bacterial and virus vaccines and other pharmaceutical products. The company is based in Gurgaon, India. |
Pharmaceuticals: Major
|
GSK Capital KK
|
Finance/Rental/Leasing
|
Horlicks Ltd.
 Horlicks Ltd. Beverages: AlcoholicConsumer Non-Durables Horlicks Ltd. manufactures and distributes infant food products. The products it offers are Horlicks traditional, light and light chocolate. The company was founded on December 11, 1925 and is headquartered in Brentford, the United Kingdom. |
Beverages: Alcoholic
|
GlaxoSmithKline GmbH & Co. KG
 GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. |
Pharmaceuticals: Major
|
Setfirst Ltd.
 Setfirst Ltd. Financial ConglomeratesFinance Part of GSK Plc, Setfirst Ltd. functions as an investment holding British company. The company is based in Middlesex, UK. |
Financial Conglomerates
|
GlaxoSmithKline Pte Ltd.
 GlaxoSmithKline Pte Ltd. Pharmaceuticals: OtherHealth Technology GlaxoSmithKline Pte Ltd. engages in pharmaceutical products. It provides prescription medicines, vaccines, and consumer healthcare services. The company is headquartered in Gateway West, Singapore. |
Pharmaceuticals: Other
|
SmithKline Beecham Overseas Ltd.
 SmithKline Beecham Overseas Ltd. MiscellaneousMiscellaneous Founded in 1990, SmithKline Beecham Overseas Ltd. is a British holdings company that operates as a subsidiary of GSK Plc. The company is based in Middlesex, UK. |
Miscellaneous
|
GlaxoSmithKline Capital Plc
|
Finance/Rental/Leasing
|
GlaxoSmithKline Export Ltd.
 GlaxoSmithKline Export Ltd. Medical DistributorsDistribution Services Part of GSK Plc, GlaxoSmithKline Export Ltd. is a British biopharma company founded in 1989. The company is based in Middlesex, UK. GlaxoSmithKline Export aims to unite science, technology, and talent to get ahead of disease together. The company's pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative vaccines and medicines. |
Medical Distributors
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| +23,05% | 92,17 Mrd | |
| +38,69% | 728 Mrd | |
| +33,85% | 603 Mrd | |
| -4,49% | 360 Mrd | |
| +20,24% | 332 Mrd | |
| +2,12% | 279 Mrd | |
| +16,02% | 244 Mrd | |
| +7,72% | 207 Mrd | |
| -5,56% | 205 Mrd | |
| -0,35% | 163 Mrd |
- Borsa valori
- Azioni
- Azione GSK
- Società GSK plc